Answers are grounded in this paper and cite their sources.
Investigation reveals adrenal glands contribute to circulating inhibin-LI levels in hypogonadal individuals, suggesting important hormonal roles.
To clarify the contribution of the inhibin-like immunoreactivity (inhibin-LI) produced by adrenal glands to the total circulating levels of inhibin-LI, we measured serum inhibin-LI in normal and hypogonadal subjects under ACTH-loading or dexamethasone-loading conclition. The mean basal concentration of inhibin-LI in the peripheral serum of the hypogonadal cases was 3.6±1.3 IU/ml (mean±SD, n=5), which corresponded to 19.5±5.8% of that of normal controls matched for age and sex. The low levels of inhibin-LI in hypogonadal subjects (n=7) rose significantly (3.6±1.1 vs 8.1±1.7 IU/ml, p<0.001) after the administration of synthetic ^<1-24>ACTH (40 units / day intramuscular injection) for 2 days, while the levels of serum inhibin-LI were not increased in two cases of Addison's disease with hypogonadism after the administration of ACTH. After the oral administration of a low dose of dexamethasone (1 mg) the serum inhibin-LI level in normal subjects (eight males and eight females) decreased significantly (male, 16.2±3.3 vs 14.5±4.1 IU/ml; female, 12.9±6.3 vs 10.8±5.6 IU/ml; p<0.01 each) without significant change in the levels of serum gonadotropin (LH and FSH) and those of gonadal steroid (testosterone or estradiol). These results indicate that a small, but significant amount of inhibin-LI is secreted from the adrenal gland and circulating in vivo, and that the proportion of adrenal derived inhibin-LI is much higher in patients with hypogonadism.
No takes yet. Share an insight, caveat, or question.
NISHI et al. (2000) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: